» Articles » PMID: 2832148

Monoclonal Antibodies to the Insulin Receptor Stimulate the Intrinsic Tyrosine Kinase Activity by Cross-linking Receptor Molecules

Overview
Journal EMBO J
Date 1987 Dec 20
PMID 2832148
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

The effect of monoclonal anti-insulin receptor antibodies on the intrinsic kinase activity of solubilized receptor was investigated. Antibodies for six distinct epitopes stimulated receptor autophosphorylation and kinase activity towards exogenous substrates. This effect of antibodies was seen only within a narrow concentration range and monovalent antibody fragments were ineffective. Evidence was obtained by sucrose density-gradient centrifugation for the formation of antibody-receptor complexes which involved both inter- and intra-molecular cross-linking, although stimulation of autophosphorylation appeared to be preferentially associated with the latter. There was partial additivity between the effects of insulin and antibodies in stimulating autophosphorylation, although the sites of phosphorylation appeared identical on two-dimensional peptide maps. Antibodies for two further epitopes failed to activate receptor kinase, but inhibited its stimulation by insulin. The effects of antibodies on kinase activity paralleled their metabolic effects on adipocytes, except for one antibody which was potently insulin-like in its metabolic effects, but which antagonized insulin stimulation of kinase activity. It is concluded that antibodies activate the receptor by cross-linking subunits rather than by reacting at specific epitopes. The ability of some antibodies to activate receptor may depend on receptor environment as well as the disposition of epitopes.

Citing Articles

Insulin promotes growth in breast cancer cells through the type I IGF receptor in insulin receptor deficient cells.

Monteiro M, Zhang X, Yee D Exp Cell Res. 2023; 434(1):113862.

PMID: 38036052 PMC: 10842809. DOI: 10.1016/j.yexcr.2023.113862.


Activation of the insulin receptor by an insulin mimetic peptide.

Park J, Li J, Mayer J, Ball K, Wu J, Hall C Nat Commun. 2022; 13(1):5594.

PMID: 36151101 PMC: 9508239. DOI: 10.1038/s41467-022-33274-0.


Anti-Insulin Receptor Antibodies Improve Hyperglycemia in a Mouse Model of Human Insulin Receptoropathy.

Brierley G, Webber H, Rasijeff E, Grocott S, Siddle K, Semple R Diabetes. 2020; 69(11):2481-2489.

PMID: 32816962 PMC: 7576564. DOI: 10.2337/db20-0345.


Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy.

Smith T, Janssen J Endocr Rev. 2018; 40(1):236-267.

PMID: 30215690 PMC: 6338478. DOI: 10.1210/er.2018-00066.


Evaluation of anti-insulin receptor antibodies as potential novel therapies for human insulin receptoropathy using cell culture models.

Brierley G, Siddle K, Semple R Diabetologia. 2018; 61(7):1662-1675.

PMID: 29700562 PMC: 6445487. DOI: 10.1007/s00125-018-4606-2.


References
1.
Tzartos S, Lindstrom J . Monoclonal antibodies as probes of acetylcholine receptor structure. 2. Binding to native receptor. Biochemistry. 1981; 20(8):2181-91. DOI: 10.1021/bi00511a017. View

2.
Linde S, Hansen B, Sonne O, Holst J, GLIEMANN J . Tyrosine A14[125I]monoiodoinsulin: Preparation, Biologic Properties, and long-term stability. Diabetes. 1981; 30(1):1-8. DOI: 10.2337/diab.30.1.1. View

3.
Baron M, Sonksen P . Characterization of two insulin-binding components of rat-liver plasma membranes. Biosci Rep. 1982; 2(10):785-93. DOI: 10.1007/BF01114938. View

4.
Schreiber A, Libermann T, Lax I, Yarden Y, Schlessinger J . Biological role of epidermal growth factor-receptor clustering. Investigation with monoclonal anti-receptor antibodies. J Biol Chem. 1983; 258(2):846-53. View

5.
Lamoyi E, Nisonoff A . Preparation of F(ab')2 fragments from mouse IgG of various subclasses. J Immunol Methods. 1983; 56(2):235-43. DOI: 10.1016/0022-1759(83)90415-5. View